These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 37151971)
41. Core Outcome Domains for Clinical Trials on Somatic Symptom Disorder, Bodily Distress Disorder, and Functional Somatic Syndromes: European Network on Somatic Symptom Disorders Recommendations. Rief W; Burton C; Frostholm L; Henningsen P; Kleinstäuber M; Kop WJ; Löwe B; Martin A; Malt U; Rosmalen J; Schröder A; Shedden-Mora M; Toussaint A; van der Feltz-Cornelis C; Psychosom Med; 2017; 79(9):1008-1015. PubMed ID: 28691994 [TBL] [Abstract][Full Text] [Related]
42. Associations of treatment effects between follow-up times and between outcome domains in interventions for somatoform disorders: Review of three Cochrane reviews. Chowdhury S; Burton C J Psychosom Res; 2017 Jul; 98():10-18. PubMed ID: 28554364 [TBL] [Abstract][Full Text] [Related]
43. How durable is the effect of low intensity CBT for depression and anxiety? Remission and relapse in a longitudinal cohort study. Ali S; Rhodes L; Moreea O; McMillan D; Gilbody S; Leach C; Lucock M; Lutz W; Delgadillo J Behav Res Ther; 2017 Jul; 94():1-8. PubMed ID: 28437680 [TBL] [Abstract][Full Text] [Related]
44. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Gold SM; Enck P; Hasselmann H; Friede T; Hegerl U; Mohr DC; Otte C Lancet Psychiatry; 2017 Sep; 4(9):725-732. PubMed ID: 28396067 [TBL] [Abstract][Full Text] [Related]
45. Acceptance and Commitment Therapy, Relational Frame Theory, and the Third Wave of Behavioral and Cognitive Therapies - Republished Article. Hayes SC Behav Ther; 2016 Nov; 47(6):869-885. PubMed ID: 27993338 [TBL] [Abstract][Full Text] [Related]
46. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Karimi M; Brazier J Pharmacoeconomics; 2016 Jul; 34(7):645-9. PubMed ID: 26892973 [TBL] [Abstract][Full Text] [Related]
47. GOSH - a graphical display of study heterogeneity. Olkin I; Dahabreh IJ; Trikalinos TA Res Synth Methods; 2012 Sep; 3(3):214-23. PubMed ID: 26062164 [TBL] [Abstract][Full Text] [Related]
48. Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial. Cash E; Salmon P; Weissbecker I; Rebholz WN; Bayley-Veloso R; Zimmaro LA; Floyd A; Dedert E; Sephton SE Ann Behav Med; 2015 Jun; 49(3):319-30. PubMed ID: 25425224 [TBL] [Abstract][Full Text] [Related]
49. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. van Dessel N; den Boeft M; van der Wouden JC; Kleinstäuber M; Leone SS; Terluin B; Numans ME; van der Horst HE; van Marwijk H Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011142. PubMed ID: 25362239 [TBL] [Abstract][Full Text] [Related]
50. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Rief W; Martin A Annu Rev Clin Psychol; 2014; 10():339-67. PubMed ID: 24387234 [TBL] [Abstract][Full Text] [Related]
51. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study). Luciano JV; Guallar JA; Aguado J; López-Del-Hoyo Y; Olivan B; Magallón R; Alda M; Serrano-Blanco A; Gili M; Garcia-Campayo J Pain; 2014 Apr; 155(4):693-702. PubMed ID: 24378880 [TBL] [Abstract][Full Text] [Related]
52. Risk of bias: a simulation study of power to detect study-level moderator effects in meta-analysis. Hempel S; Miles JN; Booth MJ; Wang Z; Morton SC; Shekelle PG Syst Rev; 2013 Nov; 2():107. PubMed ID: 24286208 [TBL] [Abstract][Full Text] [Related]
53. Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. Lakhan SE; Schofield KL PLoS One; 2013; 8(8):e71834. PubMed ID: 23990997 [TBL] [Abstract][Full Text] [Related]
54. Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a randomized controlled trial. van Ravesteijn H; Lucassen P; Bor H; van Weel C; Speckens A Psychother Psychosom; 2013; 82(5):299-310. PubMed ID: 23942259 [TBL] [Abstract][Full Text] [Related]
55. P-curve: a key to the file-drawer. Simonsohn U; Nelson LD; Simmons JP J Exp Psychol Gen; 2014 Apr; 143(2):534-47. PubMed ID: 23855496 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of inconsistency in networks of interventions. Veroniki AA; Vasiliadis HS; Higgins JP; Salanti G Int J Epidemiol; 2013 Feb; 42(1):332-45. PubMed ID: 23508418 [TBL] [Abstract][Full Text] [Related]
57. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. Fjorback LO; Arendt M; Ornbøl E; Walach H; Rehfeld E; Schröder A; Fink P J Psychosom Res; 2013 Jan; 74(1):31-40. PubMed ID: 23272986 [TBL] [Abstract][Full Text] [Related]
58. Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial. Wicksell RK; Kemani M; Jensen K; Kosek E; Kadetoff D; Sorjonen K; Ingvar M; Olsson GL Eur J Pain; 2013 Apr; 17(4):599-611. PubMed ID: 23090719 [TBL] [Abstract][Full Text] [Related]
59. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Zernicke KA; Campbell TS; Blustein PK; Fung TS; Johnson JA; Bacon SL; Carlson LE Int J Behav Med; 2013 Sep; 20(3):385-96. PubMed ID: 22618308 [TBL] [Abstract][Full Text] [Related]
60. Cognitive Behavioral Therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Jensen KB; Kosek E; Wicksell R; Kemani M; Olsson G; Merle JV; Kadetoff D; Ingvar M Pain; 2012 Jul; 153(7):1495-1503. PubMed ID: 22617632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]